InvestLog
TRVI logo

TRVI

Trevi Therapeutics, Inc.NASDAQHealthcare
$11.94+3.11%ClosedMarket Cap: $1.53B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-19Jones Trading—Buy—
2026-03-18Morgan Stanley—Overweight—
2026-03-18Needham—Buy—
2026-03-18D. Boral Capital—Buy—
2026-03-09HC Wainwright & Co.—Buy—
2026-01-09HC Wainwright & Co.—Buy—
2026-01-08D. Boral Capital—Buy—
2025-12-19Stifel—Buy—
2025-11-20Leerink Partners—Outperform—
2025-11-14Oppenheimer—Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.60$3.5M8
Sun Dec 31$-0.58$31.9M9
Mon Dec 31$-0.33$135.5M3
Tue Dec 31$0.88$416.7M3